Roles of the lipid metabolism in hepatic stellate cells activation

Chinese Medical Sciences Journal

Volumn 28, Issue 4, 2013, Pages 233-236

  Jing, Xin Yan ^a   Yang, Xue Feng ^a   Qing, Kai ^b   Ou Yang, Yan ^b  

^a UNIVERSITY OF SOUTH CHINA   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

cell activation; cholesterol; hepatic stellate cells; triglyceride; vitamin A

Indexed keywords

CHOLESTEROL; RETINOL; TRIACYLGLYCEROL;

CELL ACTIVATION; CHOLESTEROL METABOLISM; HUMAN; LIPID METABOLISM; NONHUMAN; REVIEW; STELLATE CELL; VITAMIN METABOLISM;

ANIMALS; CHOLESTEROL; HEPATIC STELLATE CELLS; HUMANS; LIPID METABOLISM; TRIGLYCERIDES; VITAMIN A;

EID: 84891838750     PISSN: 10019294     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1001-9294(14)60008-0     Document Type: Review

References (27)

1. WS Blaner, SM O'Byrne, N Wongsiriroj et al. Hepatic stellate cell lipid droplets: A specialized lipid droplet for retinoid storage Biochim Biophys Acta 1791 2009 467 473
2. N Testerink, M Ajat, M Houweling et al. Replacement of retinyl esters by polyunsaturated triacylglycerol species in lipid droplets of HSCs during activation PLoS One 7 2012 e34945
3. V Herńndez-Gea, SL Friedman Autophagy fuels tissue fibrogenesis Autophagy 8 2012 849 850
4. Y Tang, A Chen Curcumin protects HSCs against leptininduced activation in vitro by accumulating intracellular lipids Endocrinology 151 2010 4168 4177
5. H Tsukamoto Fat paradox in liver disease Keio J Med 54 2005 190 192 (Pubitemid 43200934)
6. A Chen, Y Tang, V Davis et al. Liver fatty acid binding protein (L-Fabp) modulates murine stellate cell activation and diet induced nonalcoholic fatty liver disease Hepatology 57 2013 2202 2212
7. W Zhang, R Wu, F Zhang et al. Thiazolidinediones improve hepatic fibrosis by activating the adenosine monophosphate-activated protein kinase (ampk) signaling pathway in rats with non-alcoholic steatohepatitis Clin Exp Pharmacol Physiol 39 2012 1026 1033
8. EF Gäbele, C Dorn, E Patsenker et al. A new model of interactive effects of alcohol and high-fat diet on hepatic fibrosis Alcohol Clin Exp Res 35 2011 1361 1367
9. S Nakano, T Nagasawa, T Ijiro et al. Bezafibrate prevents HSCs activation and fibrogenesis in a murine steatohepatitis model, and suppresses fibrogenic response induced by transforming growth factor-beta1 in a cultured stellate cell line Hepatol Res 38 2008 1026 1039
10. A Galli, D Crabb, D Price et al. Peroxisome proliferator-activated receptor gamma transcriptional regulation is involved in platelet-derived growth factor-induced proliferation of human HSCs Hepatology 31 2000 101 108 (Pubitemid 30033695)
11. L Dubuquoy, S Dharancy, S Nutten et al. Role of peroxisome proliferator-activated receptor gamma and retinoid X receptor heterodimer in hepatogastroenterological diseases Lancet 360 2002 1410 1418 (Pubitemid 35341309)
12. M Kainuma, M Fujimoto, N Sekiya et al. Cholesterol-fed rabbit as a unique model of nonalcoholic, nonobese, non-insulin-resistant fatty liver disease with characteristic fibrosis J Gastroenterol 41 2006 971 980 (Pubitemid 44741410)
13. N Ferré, M Martínez-Clemente, M López-Parra et al. Increased susceptibility to exacerbated liver injury in hyper-cholesterolemic ApoE-deficient mice: Potential involvement of oxysterols Am J Physiol Gastrointest Liver Physiol 296 2009 G553 G562
14. HK Min, A Kapoor, M Fuchs et al. Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease Cell Metab 15 2012 665 674
15. J Bie, B Zhao, J Song et al. Improved insulin sensitivity in high fat- and high cholesterol-fed Ldlr-/- mice with macrophage-specific transgenic expression of cholesteryl ester hydrolase: Role of macrophage inflammation and infiltration into adipose tissue J Biol Chem 285 2010 13630 13637
16. M Vincent, NL Sayre, MJ Graham et al. Evaluation of an anti-tumor necrosis factor therapeutic in a mouse model of Niemann-Pick C liver disease PLoS One 5 2010 e12941
17. V Bieghs, T Hendrikx, PJ van Gorp et al. The cholesterol derivative 27-hydroxycholesterol reduces steatohepatitis in mice Gastroenterology 144 2013 167 178
18. T Tokunaga, T Ikegami, T Yoshizumi et al. Beneficial effects of fluvastatin on liver microcirculation and regeneration after massive hepatectomy in rats Dig Dis Sci 53 2008 2989 2994
19. I Aprigliano, J Dudas, G Ramadori et al. Atorvastatin induces apoptosis by a caspase-9-dependent pathway: An in vitro study on activated rat HSCs Liver Int 28 2008 546 557 (Pubitemid 351411142)
20. Q Yang, HY Liu, YW Zhang et al. Anandamide induces cell death through lipid rafts in HSCs J Gastroenterol Hepatol 25 2010 991 1001
21. T Li, JY Chiang A novel role of transforming growth factor beta1 in transcriptional repression of human cholesterol 7 alpha-hydroxylase gene Gastroenterology 133 2007 1660 1669 (Pubitemid 350029751)
22. YS Lee, WI Jeong Retinoic acids and HSCs in liver disease J Gastroenterol Hepatol 27 2012 S75 S79
23. H Senoo, K Yoshikawa, M Morii et al. HSCs (vitamin A-storing cell) and its relative - past, present and future Cell Biol Int 34 2010 1247 1272
24. B Mukhopadhyay, J Liu, D Osei-Hyiaman et al. Transcriptional regulation of cannabinoid receptor-1 expression in the liver by retinoic acid acting via retinoic acid receptor-gamma J Biol Chem 285 2010 19002 19011
25. H He, A Mennone, JL Boyer et al. Combination of retinoic acid and ursodeoxycholic acid attenuates liver injury in bile duct-ligated rats and human hepatic cells Hepatology 53 2011 548 557
26. TF Lee, KM Mak, O Rackovsky et al. Downregulation of hepatic stellate cell activation by retinol and palmitate mediated by adipose differentiation-related protein (ADRP) J Cell Physiol 223 2010 648 657
27. G Son, IN Hines, J Lindquist et al. Inhibition of phosphatidy-linositol 3-kinase signaling in HSCs blocks the progression of hepatic fibrosis Hepatology 50 2009 1512 1523